Torsten Schultz-Fademrecht, Boehringer Ingelheim - Qepler Summits And Conferences

Torsten Schultz-Fademrecht

Scientist Pharmaceutical Dev. Biologicals
Boehringer Ingelheim
Hamburg, Germany
 Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.

Torsten studied chemistry at the University of Paderborn, Germany. He hold an engineering degree.

He has experience of about 20 years in powder technologies for stabilizing proteins. This include spray drying, precipitation technologies and freeze

drying. He was involved in the development of platform technologies, like inhalable biopharmaceutics.

He is actually scientist in the biopharmaceutical early stage drug product development of Boehringer-Ingelheim, Biberach.

Related Sessions:

Pharmaceutical Lyophilization
Summit 2019

Discuss best practices in tech & regulatory updates, process, formulation, testing, monitoring and new products development.
  • 13 Feb 2019
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 13 February 2019
CASE STUDY: Freeze-Drying of High Concentration Biologics.
  • What are high concentration biologics?
  • CMC issues for high concentrated biologics
  • Challenges encountered for freeze drying thereof
View Details